News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

The hallmark of a good AI model is its ability to work the same in different groups, settings, and situations. See how these NCI researchers used in-house and external images to test their prostate model’s generalizability.

Want to learn more about bioinformatics? Tap into these two newly published articles to see what some prominent researchers are saying about the field and where it’s headed.

Construction of the Advanced Research Projects Agency for Health’s (ARPA-H’s) BDF Toolbox program is well underway. ARPA-H has awarded contracts to nearly 20 teams—representing academia, nonprofits, and commercial organizations—who are tackling a broad range of projects, many of which are directly related to cancer research.

Thanks to funding from NCI’s Small Business Innovation Research program, a new tool recently received FDA clearance. See how this cyber device could help you with artificial intelligence (AI)-guided glioblastoma segmentation.

An international team of researchers combined genomics, biopsy results, and artificial intelligence (AI) to track prostate cancer over time. Learn more about these “evolvability” metrics and how they could someday help predict cancer re-occurrence.

NCI-funded researchers are blending mathematics with machine learning to refine cancer treatment. In the future, this kind of virtual tumor model could help to further personalize care for people with cancer.

NCI researchers are using artificial intelligence (AI) to uncover additional information from medical images. This helps them not only to diagnose cancer but also to predict how it will progress and if it will re-occur.

A new, scalable, machine learning model is helping scientists model thousands of transcription factors and genes in the human genome, providing new information on these genes and how they work/change over time.

Learn how supercomputing and cancer research expertise helped transform a previously complex, ‘undruggable’ target into a promising, first-in-class medication. Researchers are now testing it in human trials.

Are you developing machine learning and looking for ways to make your model generalizable to a diverse population? A recent study describes an algorithm that centers on transforming your data rather than tweaking your model.